Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Tff Pharmaceuticals Inc (TFFP) USD0.001

Sell:$6.92 Buy:$7.00 Change: $0.24 (3.33%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.24 (3.33%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.24 (3.33%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company. The Company is focused on developing and commercializing drug products based on its Thin Film Freezing (TFF) technology platform. Its TFF platform is designed to enable solubility of poorly water-soluble drugs. Its drug candidates include TFF Vori, TFF Tac-Lac and Triple Combination For chronic obstructive pulmonary disease (COPD)/Asthma. It is developing TFF Vori for the treatment of invasive pulmonary aspergillosis (IPA). TFF Vori is being developed as an inhaled dry powder drug. It is developing TFF Tac-Lac for Immunosuppression to prevent organ transplant rejection. TFF Tac-Lac is being developed as a dry powder version of Tacrolimus, an immunosuppressive drug used in transplant medicine. It is also developing a combination dry powder drug intended for use with a dry powder inhaler for the maintenance treatment of bronchospasm associated with moderate to severe COPD.

Contact details

2600 Via Fortuna Ste 360
United States
+ ()

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$187.75 million
Shares in issue:
25.37 million
United States
US dollar

Key personnel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.